New hope for Kids' asthma? trial tests breathing drug

NCT ID NCT05222529

Summary

This study is testing an inhaled drug called glycopyrronium to see if it helps children aged 6 to 12 with moderate to severe asthma breathe better. About 42 children will try two different doses of the drug and a placebo (an inactive substance) in a random order to compare their effects. The main goal is to find the right dose to use in a future combination asthma treatment for kids.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Novartis Investigative Site

    RECRUITING

    Rousse, 7002, Bulgaria

  • Novartis Investigative Site

    RECRUITING

    Sevlievo, 5400, Bulgaria

  • Novartis Investigative Site

    RECRUITING

    Sofia, 1510, Bulgaria

  • Novartis Investigative Site

    RECRUITING

    Ibagué, Tolima Department, 730006, Colombia

  • Novartis Investigative Site

    WITHDRAWN

    Guatemala City, GTM, 01010, Guatemala

  • Novartis Investigative Site

    RECRUITING

    Guatemala City, 01015, Guatemala

  • Novartis Investigative Site

    RECRUITING

    Debrecen, Hajdu Bihar Megye, 4032, Hungary

  • Novartis Investigative Site

    RECRUITING

    Budapest, 1033, Hungary

  • Novartis Investigative Site

    RECRUITING

    Budapest, H-1083, Hungary

  • Novartis Investigative Site

    RECRUITING

    Eger, 3300, Hungary

  • Novartis Investigative Site

    WITHDRAWN

    Kaposvár, 7400, Hungary

  • Novartis Investigative Site

    WITHDRAWN

    Nagykanizsa, 8800, Hungary

  • Novartis Investigative Site

    RECRUITING

    Szigetvár, 7900, Hungary

  • Novartis Investigative Site

    RECRUITING

    Tarnów, 33-100, Poland

  • Novartis Investigative Site

    RECRUITING

    Lodz, Łódź Voivodeship, 90-329, Poland

  • Novartis Investigative Site

    RECRUITING

    George, Western Cape, 6529, South Africa

  • Novartis Investigative Site

    RECRUITING

    Cape Town, 7531, South Africa

  • Novartis Investigative Site

    RECRUITING

    Esplugues, Barcelona, 08950, Spain

  • Novartis Investigative Site

    RECRUITING

    Sabadell, Barcelona, 08208, Spain

  • Novartis Investigative Site

    WITHDRAWN

    Mérida, Extremadura, 06800, Spain

  • Novartis Investigative Site

    RECRUITING

    Barcelona, 08035, Spain

  • Novartis Investigative Site

    RECRUITING

    London, SE5 9RS, United Kingdom

  • Novartis Investigative Site

    RECRUITING

    Stoke-on-Trent, ST4 6QG, United Kingdom

Conditions

Explore the condition pages connected to this study.